Biotech SF
San Francisco Bay Area biotech stories.
Tuesday, February 1, 2011
Allergan, Map Pharmaceuticals in migraine drug deal worth up to $157M
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment